TMC8
Transmembrane channel-like protein 8
Also known as: EVER2, EVIN2, TMC8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IU68
- Gene
- TMC8
- Ensembl
- ENSG00000167895
- Chromosome
- 17
- Canonical length
- 726 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 8 predicted transmembrane domains and 3 leucine zipper motifs. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
726 residues, UniProt reviewed canonical sequence.
>Q8IU68|TMC8
1 MLLPRSVSSE RAPGVPEPEE LWEAEMERLR GSGTPVRGLP YAMMDKRLIW QLREPAGVQT
61 LRWQRWQRRR QTVERRLREA AQRLARGLGL WEGALYEIGG LFGTGIRSYF TFLRFLLLLN
121 LLSLLLTASF VLLPLVWLRP PDPGPTLNLT LQCPGSRQSP PGVLRFHNQL WHVLTGRAFT
181 NTYLFYGAYR VGPESSSVYS IRLAYLLSPL ACLLLCFCGT LRRMVKGLPQ KTLLGQGYQA
241 PLSAKVFSSW DFCIRVQEAA TIKKHEISNE FKVELEEGRR FQLMQQQTRA QTACRLLSYL
301 RVNVLNGLLV VGAISAIFWA TKYSQDNKEE SLFLLLQYLP PGVIALVNFL GPLLFTFLVQ
361 LENYPPNTEV NLTLIWCVVL KLASLGMFSV SLGQTILCIG RDKSSCESYG YNVCDYQCWE
421 NSVGEELYKL SIFNFLLTVA FAFLVTLPRR LLVDRFSGRF WAWLEREEFL VPKNVLDIVA
481 GQTVTWMGLF YCPLLPLLNS VFLFLTFYIK KYTLLKNSRA SSRPFRASSS TFFFQLVLLL
541 GLLLAAVPLG YVVSSIHSSW DCGLFTNYSA PWQVVPELVA LGLPPIGQRA LHYLGSHAFS
601 FPLLIMLSLV LTVCVSQTQA NARAIHRLRK QLVWQVQEKW HLVEDLSRLL PEPGPSDSPG
661 PKYPASQASR PQSFCPGCPC PGSPGHQAPR PGPSVVDAAG LRSPCPGQHG APASARRFRF
721 PSGAELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMC8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 108 nTPM
Expression across tissuesHPA
Tissue
- spleen: 108 nTPM
- lymph node: 71 nTPM
- bone marrow: 70 nTPM
- thymus: 49 nTPM
- small intestine: 48 nTPM
- tonsil: 38 nTPM
Single-cell type
- nk-cells: 173 nCPM
- t-cells: 161 nCPM
- b-cells: 140 nCPM
- neutrophil progenitors: 103 nCPM
- hofbauer cells: 87 nCPM
- innate lymphoid cells: 86 nCPM
Immune cell
- memory CD8 T-cell: 12 nTPM
- gdT-cell: 12 nTPM
- memory CD4 T-cell: 9.9 nTPM
- MAIT T-cell: 8.4 nTPM
- naive CD4 T-cell: 8.2 nTPM
- naive CD8 T-cell: 7.6 nTPM
Brain region
- thalamus: 8.7 nTPM
- white matter: 7 nTPM
- medulla oblongata: 5.9 nTPM
- pons: 5.7 nTPM
- spinal cord: 5.2 nTPM
- cerebral cortex: 4.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TMC8.
Disease | AllUniProt
Conditions TMC8 is implicated in, by any mechanism.
- Epidermodysplasia verruciformis 2 (EV2) MIM:618231
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 729 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Epidermodysplasia verruciformis
- Epidermodysplasia verruciformis, susceptibility to, 2
- Epidermodysplasia verruciformis, susceptibility to, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular zinc ion homeostasis
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of protein binding
- negative regulation of protein-containing complex assembly
- positive regulation of apoptotic process
- protein stabilization
- regulation of extrinsic apoptotic signaling pathway via death domain receptors
- regulation of tumor necrosis factor-mediated signaling pathway
Molecular functions
- mechanosensitive monoatomic ion channel activity
- protein sequestering activity
- tumor necrosis factor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMC8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMC8 as an antibody target. Whether an autoantibody or antibody against TMC8 could matter depends on whether native TMC8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMC8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMC8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...